NASDAQ:ENGN enGene (ENGN) Stock Price, News & Analysis → The only AI company to buy (From Porter & Company) (Ad) Free ENGN Stock Alerts $7.95 +0.25 (+3.25%) (As of 06/5/2024 ET) Add Compare Share Share Today's Range$6.91▼$8.1150-Day Range$7.70▼$17.2452-Week Range$6.69▼$43.00Volume35,308 shsAverage Volume54,368 shsMarket Capitalization$346.46 millionP/E RatioN/ADividend YieldN/APrice Target$34.40 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get enGene alerts: Email Address enGene MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside332.7% Upside$34.40 Price TargetShort InterestHealthy0.31% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$786,481 Sold Last QuarterProj. Earnings GrowthDecreasingFrom ($1.03) to ($1.22) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.59 out of 5 starsMedical Sector415th out of 904 stocksHolding & Other Investment Offices Industry3rd out of 15 stocks 3.5 Analyst's Opinion Consensus RatingenGene has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageenGene has only been the subject of 4 research reports in the past 90 days.Read more about enGene's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.31% of the float of enGene has been sold short.Short Interest Ratio / Days to CoverenGene has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in enGene has recently decreased by 12.39%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldenGene does not currently pay a dividend.Dividend GrowthenGene does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ENGN. Previous Next 1.3 News and Social Media Coverage News SentimentenGene has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for enGene this week, compared to 25 articles on an average week.MarketBeat FollowsOnly 1 people have added enGene to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, enGene insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $786,481.00 in company stock.Percentage Held by Insiders13.70% of the stock of enGene is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.16% of the stock of enGene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about enGene's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for enGene are expected to decrease in the coming year, from ($1.03) to ($1.22) per share. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. About enGene Stock (NASDAQ:ENGN)enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.Read More ENGN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ENGN Stock News HeadlinesMay 29, 2024 | msn.comThe U.S. Air Force's 'New' B-52J Bomber Has Rolls-Royce EnginesMay 29, 2024 | msn.comToyota, Mazda, and Subaru Collaborating on Next-Gen EnginesMay 29, 2024 | msn.comAre Turbocharged Engines More Or Less Reliable Than Regular Engines?May 29, 2024 | businesswire.comenGene to Present at the Jefferies Global Healthcare ConferenceMay 28, 2024 | msn.comToyota, Mazda and Subaru aren’t ready to give up on “real” engines any time soonMay 28, 2024 | msn.comToyota shows ‘an engine reborn’ with green fuel despite global push for battery electric carsMay 28, 2024 | ft.comToyota bets on new line of combustion engines in challenge to TeslaMay 28, 2024 | msn.comUnited flight aborts takeoff at Chicago’s O’Hare airport after reported engine fire, prompting officials to delay arrivalsMay 28, 2024 | yahoo.comToyota, Mazda and Subaru team up to develop carbon-neutral enginesMay 28, 2024 | news.yahoo.comUnited Aircraft Engine Catches Fire Just Before Takeoff at Chicago O'HareMay 28, 2024 | msn.comShocking moment plane engine catches fire before takeoff at Chicago airportMay 28, 2024 | bbc.comMuseum donates fire engine to brigade in CroatiaMay 28, 2024 | msn.comUnited Airlines Flight Aborts Takeoff After Engine Catches FireMay 27, 2024 | msn.comSingle-engine plane crashes in Wicomico County fieldMay 27, 2024 | msn.com3 Of The Most Common Problems Drivers Report With The 3.0 Duramax Diesel EngineMay 27, 2024 | yahoo.comKitten Rescued From Fire Engine by Firefighters in OhioMay 27, 2024 | msn.comWhat Engine Is In Yamaha's YZF-R7 Motorcycle & Is It Faster Than The R6?May 27, 2024 | msn.comAfter a 7-year delay, San Diego has a roving fire engine for one tough-to-reach area — and more may come soonMay 27, 2024 | msn.comEverything You Need To Know About The Buick 455 EngineMay 26, 2024 | msn.comWhich Cars Came Equipped With Nissan's RB26 Engines & What Makes It So Powerful?May 26, 2024 | morningstar.comenGene Holdings Inc ENGNMay 25, 2024 | msn.comHow Difficult Is An EcoBoost Engine Swap, And How Much Will It Cost?May 25, 2024 | msn.com‘Hellcat Mike’ Charged With Stealing Dodge V8s for Engine SwapsMay 25, 2024 | msn.comSpaceX Raptor engine test ends in a fiery explosionMay 24, 2024 | msn.comBaby box blessed at Louisville Fire Department Engine 8See More Headlines Receive ENGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for enGene and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/05/2024Fiscal Year End10/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:ENGN Previous SymbolNASDAQ:ENGN CUSIPN/A CIK1980845 Webwww.engene.com Phone302-273-0765FaxN/AEmployees31Year FoundedN/APrice Target and Rating Average Stock Price Target$34.40 High Stock Price Target$40.00 Low Stock Price Target$30.00 Potential Upside/Downside+358.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$30,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-2.39% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.66) per share Price / Book-11.36Miscellaneous Outstanding Shares43,580,000Free Float37,610,000Market Cap$326.85 million OptionableN/A Beta-0.65 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Jason D. Hanson Esq. (Age 55)J.D., CEO & Director Comp: $656.58kDr. Alex Nichols Ph.D. (Age 38)President & COO Comp: $504.44kDr. James C. Sullivan M.Sc. (Age 45)Ph.D., Chief Scientific Officer Comp: $524.29kDr. Anthony T. Cheung Ph.D. (Age 52)Co-Founder & CTO Comp: $341.75kMr. John C. Brown D.Sc.FRSC, Ph.D., Co-Founder and Member of Scientific Advisory BoardMr. David Ryan Daws (Age 50)CFO & Head of Business Development Mr. Lee G. Giguere (Age 43)Chief Legal Officer & Corporate Secretary Ms. Sharon TanVP of Project Management & Head of Program ManagementDr. Richard P. Bryce MBChB (Age 67)MFPM, MRCGP, Chief Medical Officer Dr. Raj Pruthi M.D.Senior VP of Urologic Oncology & Clinical DevelopmentMore ExecutivesKey CompetitorsBain Capital Specialty FinanceNYSE:BCSFChurchill Capital Corp VIINYSE:CVIITrinity CapitalNASDAQ:TRINCION InvestmentNYSE:CIONAres Acquisition Co. IINYSE:AACTView All CompetitorsInsiders & InstitutionsJanus Henderson Group PLCBought 1,000,000 shares on 5/16/2024Ownership: 2.295%Altitude Crest Partners Inc.Bought 120,289 shares on 5/15/2024Ownership: 0.276%De Solidarite Des Travai FondsSold 47,854 sharesTotal: $717,810.00 ($15.00/share)De Solidarite Des Travai FondsSold 4,575 sharesTotal: $68,670.75 ($15.01/share)Fcpm Iii Services B.V.Bought 8,677,951 shares on 3/7/2024Ownership: 37.408%View All Insider TransactionsView All Institutional Transactions ENGN Stock Analysis - Frequently Asked Questions Should I buy or sell enGene stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for enGene in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ENGN shares. View ENGN analyst ratings or view top-rated stocks. What is enGene's stock price target for 2024? 6 brokers have issued twelve-month target prices for enGene's stock. Their ENGN share price targets range from $30.00 to $40.00. On average, they anticipate the company's share price to reach $34.40 in the next year. This suggests a possible upside of 332.7% from the stock's current price. View analysts price targets for ENGN or view top-rated stocks among Wall Street analysts. How have ENGN shares performed in 2024? enGene's stock was trading at $9.23 at the beginning of the year. Since then, ENGN stock has decreased by 13.9% and is now trading at $7.95. View the best growth stocks for 2024 here. Are investors shorting enGene? enGene saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 19,800 shares, a decline of 12.4% from the April 30th total of 22,600 shares. Based on an average trading volume of 58,000 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.3% of the company's stock are short sold. View enGene's Short Interest. Who are enGene's major shareholders? enGene's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Janus Henderson Group PLC (2.29%) and Altitude Crest Partners Inc. (0.28%). View institutional ownership trends. How do I buy shares of enGene? Shares of ENGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ENGN) was last updated on 6/5/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredPlease, take this warning seriously todayWall Street Legend Warns "Mass Bank Run" is Coming Man who predicted 2023 bank run warns it could soon get ...Chaikin Analytics | SponsoredThe Petrodollar Scheme Comes to an EndThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored[Webinar] Understanding Covered CallsDiscover the details of this option-selling strategy.OIC | SponsoredWhat’s Pelosi Buying Now?They Make the Top Investors Look Like Amateurs They beat the market for three years straight… avoided some ...Altimetry | Sponsored[Urgent!] Generational Wealth GameplanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan ...Crypto 101 Media | SponsoredClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an eff...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enGene Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share enGene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
